Who is the CEO of GYRE? | Glauxie AI

Q: Who is the CEO of GYRE?

Gyre Therapeutics, Inc. (GYRE) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Ping Zhang. Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis. It offers... Employees: 200,000.

Q: What does GYRE company do?

Learn what GYRE does — business model, products, services, revenue segments, and company history.

Q: Are insiders buying or selling GYRE?

Track recent insider buys and sells for GYRE with transaction details, amounts, and trends.

Q: What sector is GYRE in?

Find GYRE sector, industry, and sub-industry classification with sector peer comparison.

Who is the CEO of GYRE?

🦉

Gyre Therapeutics, Inc. (GYRE)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOPing Zhang

Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis. It offers ETUARY (Pirfenidone), an anti-fibrotic drug approved for the treatment of idiopathic pulmonary...

Key Executives

Name	Title
Han Ying	Senior Vice President of Science
Jialiang Wang	Executive VP & GM
Jing Liu	Senior Vice President of Platform Chemistry
Joshua Bergmann	General Counsel & Corporate Secretary
Mark Marino	Senior Vice President of Clinical Development
Michael Plewe	Senior Vice President - Medicinal Chemistry

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

GYRE Profile Financials

What does GYRE company do? Are insiders buying or selling GYRE? What sector is GYRE in?